Akademik Veri Yönetim Sistemi
Sarper N. (Yürütücü), Zengin E., Aylan Gelen S., Omay O.
Diğer Uluslararası Fon Programları, 2019 - 2019
Feasibility Assessment for: A Phase 3, multicenter, single-arm, open label study of the efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in the Treatment of Patients with Congenital Hemophilia A with Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures
We used the product in a minor surgery (port-catheter insertion) and completed the study succesfully without any complication.